UBS clients raise $650 mln for biggest yet biotech impact fund

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

How Venture Capitalists Are Deforming Capitalism

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

Gates Foundation pours cash into British firm Exscientia to fight pandemics

Arabesque launches the world’s first AI-powered ESG portfolio manager

How data is helping European VCs find their next hidden gems

Google’s DeepMind turns first profit as revenues soar